Skip to main content
Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology-Response.
Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
Opportunities for trauma-informed medical care in cystic fibrosis.
Time to be blunt: Substance use in cystic fibrosis.
Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis.
Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia.
Detection of disease-causing CFTR variants in state newborn screening programs.
Pulmonary hypertension is an important co-morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia.